Legal Opinion
Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC
Court of Appeals for the Federal Circuit
Decided July 13, 2018No. 2017-1671; 2017-1673; 2017-1674; 2017-1675; 2017-1676; 2017-1677; 2017-2075PublishedCited by 16 opinions
1Opinion of the Court
Lourie, Circuit Judge.
Jazz Pharmaceuticals, Inc. ("Jazz") appeals from six inter partes review ("IPR") decisions of the United States Patent and Trademark Office Patent Trial and Appeal Board (the "Board"). Collectively, the decisions held certain claims of Jazz's U.S. Patents 7,668,730 ("'730 patent"), 7,765,106, 7,765,107, 7,895,059, 8,589,182, 8,457,988 ("'988 patent"), and 8,731,963 ("'963 patent") (together, the "patents in suit") invalid as obvious. Because the Board did not err in its conclusions of obviousness, we affirm.
BACKGROUND
The patents in suit are members of a family of patents…
2Cases cited25 opinions
- Consolidated Edison Co. v. National Labor Relations BoardSupreme Court of the United States · 1938
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Teva Pharm. United States, Inc. v. Sandoz, Inc.Supreme Court of the United States · 2015
- In Re Robert J. Gartside and Richard C. NortonCourt of Appeals for the Federal Circuit · 2000
20 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Acceleration Bay, LLC v. Activision Blizzard Inc.Court of Appeals for the Federal Circuit · 2018
- Nobel Biocare Services Ag v. Instradent USA, Inc.Court of Appeals for the Federal Circuit · 2018
- Gopro, Inc. v. Contour IP Holding LLCCourt of Appeals for the Federal Circuit · 2018
- Samsung Electronics Co., Ltd. v. Infobridge Pte. Ltd.Court of Appeals for the Federal Circuit · 2019
- Vidstream LLC v. Twitter, Inc.Court of Appeals for the Federal Circuit · 2020
11 more not listed; retrieve them via the Exa API.